Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma

DNA and Cell Biology

Volumn 19, Issue 2, 2000, Pages 79-91

  Yan, Shiqing ^a   Berquin, Isabelle M ^b   Troen, Bruce R ^c   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B;

ARTICLE; ELECTROPHORETIC MOBILITY; EXPRESSION VECTOR; GENETIC ANALYSIS; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; RNA TRANSCRIPTION;

DROSOPHILA;

EID: 0034008432     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454900314591     Document Type: Article

References (67)

1. Anderson, G.M., and Freytag, S.O. (1991). Synergistic activation of a human promoter in vivo by transcription factor Sp1. Mol. Cell Biol. 11, 1935-1943.
2. 2+ -ATPase gene promoter are required for expression in So18 muscle cells. J. Biol. Chem. 271, 5921-5928.
3. Barrett, A.J., and Kirschke, H. (1981). Cathepsin B, Cathepsin H, and Cathepsin L. Methods Enzymol. 80, 535-561.
4. Bigner, D.D., Bigner, S.H., Ponten, J., Westermark, B., Mahaley, M.S., Ruoslahti, E., Herschman, H., Eng, L.F., and Wikstrand, C.J. (1981). Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40, 201-229.
5. Blake, M.C., Jambou, R.C., Swick, A.G., Kahn, J.W., and Azizkhan, J.C. (1990). Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol. 10, 6632-6641.
6. Block, K.L., Shou, Y., and Poncz, M. (1996). An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 88, 2071-2080.
7. Bolon, I., Gouyer, V., Devouassoux, M., Vandenbunder, B., Wernert, N., Moro, D., Brambilla, C., and Brambilla, E. (1995). Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 147, 1298-1310.
8. Borellini, F., Aquino, A., Josephs, S.F., and Glazer, R.I. (1990). Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 lekemia cells. Mol. Cell. Biol. 10, 5541-5547.
9. Borellini, F., He, Y.F., Aquino, A., Yu, G., Josephs, S.F., and Glazer, R.I. (1991). Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene. J. Biol. Chem. 266, 15850-15854.
10. Buttice, G., Duterque-Coquillaud, M., Basuyaux, J.P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996). Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13, 2297-2306.
11. Campos-Caro, A., Carrasco-Serrano, C., Valor, L.M., Viniegra, S., Ballesta, J.J., and Criado, M. (1999). Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor 5 subunit gene. J. Biol. Chem. 274, 4693-4701.
12. Cao, L., Taggart, R.T., Berquin, I.M., Moin, K., Fong, D., and Sloane, B.F. (1994). Human gastric adenocarcinoma cathepsin B: Isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene 139, 163-169.
13. Cataldo, A.M., and Nixon, R.A. (1990). Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl. Acad. Sci. USA 87, 3861-3865.
14. Cervella, P., Silengo, L., Pastore, C., and Altruda, F. (1993). Human beta 1-integrin gene expression is regulated by two promoter regions. J. Biol. Chem. 268, 5148-5155.
15. Chen, L.I., Nishinaka, T., Kwan, K., Kitabayashi, I., Yokoyama, K., Fu, Y.H., Grunwald, S., and Chiu, R. (1994). The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14, 4380-4389.
16. Chodosh, L.A. (1988). DNA-protein interactions. In Current Protocols in Molecular Biology. J.A. Ausubel and L. Struhl, eds. (Greene Publishing Associates and Wiley-Intersciences, New York) pp. 12.2.1-12.2.10.
17. Courey, A.J., and Tjian, R. (1988). Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898.
18. Courey, A.J., Holtzman, D.A., Jackson, S.P., and Tjian, R. (1989). Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827-836.
19. Delannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmels, T., Vercamer, C., Boilly, B., Vandenbunder, B., and Desbiens, X. (1998). The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J. Cell Sci. 111, 1521-1534.
20. Demchik, L.L., Sameni, M., Nelson, K., Mikkelsen, T., and Sloane, B.F. (1999). Cathepsin B and glioma invasion. Int. J. Dev. Neurosci. 17, 483-494.
21. Dennig J., Beato, M., and Suske, G. (1996). An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 15, 5659-5667.
22. Dittmer, J., and Nordheim, A. (1998). Ets transcription factors and human disease. Biochim. Biophys. Acta 1377, F1-F11.
23. Fong, D., Chan, M.M., Hsieh, W.T., Menninger, J.C., and Ward, D.C. (1992). Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8. Hum. Genet. 89, 10-12.
24. Frosch, B.A., Berquin, I.M., Emmert-Buck, M.R., Moin, K., and Sloane, B.F. (1999). Molecular regulation, membrane association and secretion of tumor cathepsin B. Acta Pathol. Microbiol. Immunol. Scand. 107, 28-37.
25. Gegonne, A., Bosselut, R., Bailly, R.A., and Ghysdael, J. (1993). Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J. 12, 1169-1178.
26. Gilles, C., Polette, M., Birembaut, P., Brunner, N., and Thompson, E.W. (1997). Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin. Exp. Metastas. 15, 519-526.
27. Gong, Q., Chan, S.J., Bajkowski, A.S., Steiner, D.F., and Frankfater, A. (1993). Characterization of the cathepsin B gene and multiple mRNAs in human tissues: Evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol. 12, 299-309.
28. Hagen, G., Muller, S., Beato, M., and Suske, G. (1992). Cloning by recognition site screening of two novel GT box binding proteins: A family of Sp1 related genes. Nucleic Acids Res. 20, 5519-5525.
29. Hagen, G., Muller, S., Beato, M., and Suske, G. (1994). Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13, 3843-3851.
30. Hagen, G., Dennig, J., Preiss, A., Beato, M., and Suske, G. (1995). Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J. Biol. Chem. 270, 24989-24994.
31. Hirano, F., Tanaka, H., Hirano, Y., Hiramoto, M., Handa, H., Makino, I., and Scheidereit, C. (1998). Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol. Cell. Biol. 13, 1266-1274.
32. Howie, A.J., Burnett, D., and Crocker, J. (1985). The distribution of cathepsin B in human tissues. Pathology 145, 307-314.
33. Huber, R., Schlessinger, D., and Pilia, G. (1998). Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene. Gene 214, 35-44.
34. Hughes, S.J., Glover, T.W., Zhu, X.X., Kuick, R., Thoraval, D., Orringer, M.B., Beer, D.G., and Hanash, S. (1998). A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA 95, 12410-12415.
35. Ji, C., Casinghino, S., McCarthy, T.L., and Centrell, M. (1997). Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-type I receptor. J. Biol. Chem. 272, 21260-21267.
36. Kadonaga, J.T., Carner, K.R., Masiarz, F.R., and Tjian, R. (1987). Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51, 1079-1090.
37. Karperien, M., Farih-Sips, H., Lowik, C.W., De Laat, S.W., Boonstra, J., and Defize, L.H. (1997). Expression of the parathyroid hormone-related peptide gene in retinoic acid-induced differentiation: Involvement of ETS and Sp1. Mol. Endocrinol. 11, 1435-1448.
38. Kennett, S.B., Udvadia, A.J., and Horowitz, J.M. (1997). Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25, 3110-3117.
39. Kim, S.J., Onwuta, U.S., Lee, Y.I., Li, R., Botchan, M.R., and Robbins, P.D. (1992). The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12, 2455-2463.
40. Kinglsey, C., and Winoto, A. (1992). Cloning of GT box-binding proteins: novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12, 4251-4261.
41. Kolkhorst, V., Sturzebecher, J., and Wiederanders, B. (1998). Inhibition of tumour cell invasion byprotease inhibitors: Correlation with the protease profile. J. Cancer Res. Clin. Oncol. 124, 598-606.
42. Kwon, H.S., Kim, M.S., Edenberg, H.J., and Hur, M.W. (1999). Sp3 and Sp4 can repress transcription by competing with Sp1 for the core cis-elements on the human ADH5/FDH minimal promoter. J. Biol. Chem. 274, 20-28.
43. Lee, J.K., Tam, J.W., Tsai, M.J., and Tsai, S.Y. (1992). Identification of cis-and trans-acting factors regulating the expression of the human insulin receptor gene. J. Biol. Chem. 267, 4638-4645.
44. Lu, J., Lee, W., Jiang, C., and Keller, E.B. (1994). Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J. Biol. Chem. 269, 5391-5402.
45. Martinez, R., Venturelli, D., Perrotti, D., Veronese, M.L., Kastury, K., Druck, T., Huebner, K., and Calabretta, B. (1997). Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related number of the nm23 gene family. Cancer Res. 57, 1180-1187.
46. Mastrangelo, I.A., Courey, A.J., Wall, J.S., Jackson, S.P., and Hough, P.V. (1991). DNA looping and Sp1 multimer links: A mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA 88, 5670-5674.
47. Moin, K., Rozhin, J., McKernan, T.B., Sanders, V.J., Fong, D., Honn, K.V., and Sloane, B.F. (1989). Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett. 244, 61-64.
48. Mort, J.S., Recklies, A.D., and Poole, A.R. (1984). Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum. 27, 509-515.
49. Noti, J.D. (1997). Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c-Jun to activate CD11C. J. Biol. Chem. 272, 24038-24045.
50. Pascal, E., and Tjian, R. (1991). Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5, 1646-1656.
51. Ponten, J., and MacIntyre, E.H. (1968). Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74, 465-486.
52. Qian, F., Bajkowski, A.S., Steiner, D.F., Chan, S.J., and Frankfater, A. (1989). Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res. 49, 4870-4875.
53. Qian, F., Chan, S.J., Gong, Q.M., Bajkowski, A.S., Steiner, D.F., and Frankfater, A. (1991a). The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors. Biomed. Biochim. Acta 50, 531-540.
54. Qian, F., Frankfater, A., Chan, S.J., and Steiner, D.F. (1991b). The structure of the mouse cathepsin B gene and its putative promoter. DNA Cell Biol. 10, 159-168.
55. Qian, F., Chan, S.J., Achkar, C., Steiner, D.F., and Frankfater, A. (1994). Transcriptional regulation of cathepsin B expression in B16 melanom as of varying metastatic potential. Biochem. Biophys. Res. Commun. 202, 429-436.
56. Rajakumar, R.A., Thamotharan, S., Menon, R.K., and Devaskar, S.U. (1998). Sp1 and Sp3 regulate transcriptional activity of the facilitative glucose transporter isoform-3 gene in mammalian neuroblasts and trophoblasts. J. Biol. Chem. 273, 27474-27483.
57. Rempel, S.A., Rosenblum, M.L., Mikkelsen, T., Yan, P.S., Ellis, K.D., Golembieski, W.A., and Sameni, M. (1994). Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54, 6027-6031.
58. Rohlff, C., Ahmad, S., Borellini, F., Lei, J., and Glazer, R.I. (1997). Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 272, 21137-21141.
59. San Segundo, B., Chan, S.J., and Steiner, D.F. (1986). Differences in cathepsin B mRNA levels in rat tissues suggest specialized functions. FEBS Lett. 201, 251-256.
60. Sinha, A.A., Gleason, D.F., Deleon, O.F., Wilson, M.J., and Sloane, B.F. (1993). Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat. Rec. 235, 233-240.
61. Sivaparvathi, M., Sawaya, R., Wang, S.W., Rayford, A., Yamamoto, M., Liotta, L.A., Nicolson, G.L., and Rao, J.S. (1995). Overexpression and localization of cathepsin B during the progression of human gliomas. Clin. Exp. Metastas. 13, 49-56.
62. Udvadia, A.J., Templeton, D.J., and Horowitz, J.M. (1995). Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: Superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA 92, 3953-3957.
63. Wang, X., Chan, S.J., Eddy, R.L., Byers, M.G., Fukushima, Y., Henry, W.M., Haley, L.L., Steiner, D.F., and Show, T.B. (1988). Chromosome assignment of cathepsin B to 8p22 and cathepsin L to 15q24-q25. Cytogenet. Cell Genet. 46, 710-711.
64. Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., and Fujinaga, K. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77, 128-137.
65. Wernert, N., Raes, M.B., Lassalle, P., Dehouck, M.P., Gosselin, B., Vandenbunder, B., and Stehelin, D. (1992). C-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140, 119-127.
66. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M.B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. (1994). Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res. 54, 5683-5688.
67. Yan, S., Sameni, M., and Sloane, B.F. (1998). Cathepsin B and human tumor progression. J. Biol. Chem. 379, 113-123.